• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《“健康的病人” 还是:基因风险如何撬动医疗体系的疾病概念》

['Healthy sick' or: How Genetic Risks Lever the Disease Concept of the Healthcare System].

作者信息

Meier Friedhelm, Ried Jens, Braun Matthias, Dabrock Peter

机构信息

Friedrich-Alexander-Universität Erlangen-Nürnberg, Fachbereich Theologie, Systematische Theologie II (Ethik).

Friedrich-Alexander-Universität Erlangen-Nürnberg, Center for Management, Technology and Society.

出版信息

Gesundheitswesen. 2017 Aug;79(8-09):594-598. doi: 10.1055/s-0043-109862. Epub 2017 Jul 14.

DOI:10.1055/s-0043-109862
PMID:28709175
Abstract

Currently it is not clear, whether and which specific prophylactic measures the healthcare system should provide as a standard offer for persons with genetic risks. Furthermore, there is no theoretical model for transparent regulation in this context. In the concrete case of BRCA1/2 carriers, the consequences of these defects become obvious: requests for medical measures are subjected to decision-making procedures of health insurance companies that are not wholly transparent. Against the background of medical advance in relation to complex diseases and in order to address this problem of the healthcare system, this article develops a healthy-sick model. This model gives a frame for identifying the medical demand of persons at risk of genetic diseases and for classifying the status of the persons concerned in the healthcare system.

摘要

目前尚不清楚医疗保健系统是否应提供以及应提供哪些具体的预防措施,作为对有遗传风险者的标准服务。此外,在这种情况下,没有用于透明监管的理论模型。在BRCA1/2基因携带者的具体案例中,这些缺陷的后果显而易见:医疗措施的申请要经过医疗保险机构的决策程序,而这些程序并不完全透明。鉴于复杂疾病方面的医学进展,为了解决医疗保健系统的这一问题,本文构建了一个健康-疾病模型。该模型为确定遗传疾病风险人群的医疗需求以及对医疗保健系统中相关人员的状况进行分类提供了一个框架。

相似文献

1
['Healthy sick' or: How Genetic Risks Lever the Disease Concept of the Healthcare System].《“健康的病人” 还是:基因风险如何撬动医疗体系的疾病概念》
Gesundheitswesen. 2017 Aug;79(8-09):594-598. doi: 10.1055/s-0043-109862. Epub 2017 Jul 14.
2
[Entitlement to prophylactic treatment in cases of genetic predisposition for breast cancer : Interdisciplinary perspectives].[乳腺癌遗传易感性病例的预防性治疗权利:跨学科视角]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Oct;60(10):1102-1108. doi: 10.1007/s00103-017-2608-8.
3
BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.BRCA1和BRCA2:突变携带者的基因检测及当前管理方案
Crit Rev Oncol Hematol. 2006 Jan;57(1):1-23. doi: 10.1016/j.critrevonc.2005.05.003. Epub 2005 Dec 6.
4
[Controlateral prophylactic mastectomy: on which arguments?].[对侧预防性乳房切除术:基于哪些论据?]
Gynecol Obstet Fertil. 2013 Jul-Aug;41(7-8):419-20. doi: 10.1016/j.gyobfe.2013.06.003. Epub 2013 Jul 18.
5
Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks.风险调整预防。在遗传(乳腺癌)风险的情况下,关于福利权益治理的观点。
Recent Results Cancer Res. 2021;218:47-66. doi: 10.1007/978-3-030-63749-1_5.
6
[Prophylactic mastectomy in women at high risk for breast cancer: indications and options].[乳腺癌高危女性的预防性乳房切除术:指征与选择]
Handchir Mikrochir Plast Chir. 2008 Aug;40(4):239-47. doi: 10.1055/s-2008-1038774. Epub 2008 Aug 20.
7
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.BRCA1 和 BRCA2 家族乳腺癌、卵巢癌和对侧乳腺癌的外显率:老年时癌症发病率高。
Breast Cancer Res Treat. 2010 Dec;124(3):643-51. doi: 10.1007/s10549-010-0805-3. Epub 2010 Mar 4.
8
Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.考虑进行BRCA1和BRCA2检测的乳腺癌和/或卵巢癌女性及其配偶的态度、知识、风险认知和决策
Psychooncology. 2003 Jul-Aug;12(5):410-27. doi: 10.1002/pon.653.
9
Family-based Breast Cancer Prevention Efforts in Adolescence.青春期基于家庭的乳腺癌预防措施
Pediatrics. 2016 Nov;138(Suppl 1):S78-S80. doi: 10.1542/peds.2015-4268K.
10
BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families.BRCA1/2 检测:在最初阴性的家族中提高检出率的方法、表型模拟和策略。
Clin Genet. 2012 Nov;82(5):478-83. doi: 10.1111/j.1399-0004.2011.01788.x. Epub 2011 Oct 19.

引用本文的文献

1
Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks.风险调整预防。在遗传(乳腺癌)风险的情况下,关于福利权益治理的观点。
Recent Results Cancer Res. 2021;218:47-66. doi: 10.1007/978-3-030-63749-1_5.
2
Just data? Solidarity and justice in data-driven medicine.仅数据而已?数据驱动医学中的团结与公正。
Life Sci Soc Policy. 2020 Aug 25;16(1):8. doi: 10.1186/s40504-020-00101-7.